Source: National Cancer Institute Thesaurus
NCI concept code for Marketing Category: C73581
NCI Thesaurus OID: 2.16.840.1.113883.3.26.1.1
|
SPL Acceptable Term |
Code |
|---|---|
| ANADA | C73583 |
| ANDA | C73584 |
| Approved Drug Product Manufactured Under Contract | C132333 |
| BLA | C73585 |
| Bulk ingredient | C73626 |
| Bulk Ingredient For Animal Drug Compounding | C98252 |
| Bulk Ingredient For Human Prescription Compounding | C96793 |
| Conditional NADA | C73588 |
| Cosmetic | C86965 |
| Dietary Supplement | C86952 |
| Drug for Further Processing | C94795 |
| Emergency Use Authorization | C96966 |
| Exempt device | C80438 |
| Export only | C73590 |
| Humanitarian Device Exemption | C80440 |
| IND | C75302 |
| Medical Food | C86964 |
| Legally Marketed Unapproved New Animal Drugs for Minor Species | C92556 |
| Multi-Market Approved Product | C175238 |
| NADA | C73593 |
| NDA | C73594 |
| NDA authorized generic | C73605 |
| OTC Monograph Drug | C200263 |
| OTC Monograph Drug Product Manufactured Under Contract | C132334 |
| OTC monograph final | C73603 |
| OTC monograph not final | C73604 |
| Outsourcing Facility Compounded Human Drug Product (Exempt From Approval Requirements) | C181659 |
| Outsourcing Facility Compounded Human Drug Product (Not Marketed - Not Distributed) | C190698 |
| Premarket Application | C80441 |
| Premarket Notification | C80442 |
| SIP Approved Drug | C175462 |
| Unapproved drug for use in drug shortage | C101533 |
| Unapproved drug other | C73627 |
| Unapproved Drug Product Manufactured Under Contract | C132335 |
| Unapproved homeopathic | C73614 |
| Unapproved medical gas | C73613 |
